181 related articles for article (PubMed ID: 32000377)
1. Primary radical hysterectomy vs chemoradiation for IB2-IIA cervical cancer: A systematic review and meta-analysis.
Yan RN; Zeng Z; Liu F; Zeng YY; He T; Xiang ZZ; Zhang BL; Gong HL; Liu L
Medicine (Baltimore); 2020 Jan; 99(5):e18738. PubMed ID: 32000377
[TBL] [Abstract][Full Text] [Related]
2. Definite chemoradiotherapy is a competent treatment option in FIGO stage IB2 cervical cancer compared with radical surgery +/- neoadjuvant chemotherapy.
Hsieh HY; Huang JW; Lu CH; Lin JC; Wang L
J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):99-108. PubMed ID: 29429800
[TBL] [Abstract][Full Text] [Related]
3. Type II or type III radical hysterectomy compared to chemoradiotherapy as a primary intervention for stage IB2 cervical cancer.
Nama V; Angelopoulos G; Twigg J; Murdoch JB; Bailey J; Lawrie TA
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD011478. PubMed ID: 30311942
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant Chemotherapy Followed by Radical Surgery versus Radiotherapy (with or without Chemotherapy) in Patients with Stage IB2, IIA, or IIB Cervical Cancer: A Systematic Review and Meta-Analysis.
Ye Q; Yang Y; Tang X; Li J; Li X; Zhang Y
Dis Markers; 2020; 2020():7415056. PubMed ID: 32802215
[TBL] [Abstract][Full Text] [Related]
5. Treatment patterns of FIGO Stage IB2 cervical cancer: a single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapy.
Zivanovic O; Alektiar KM; Sonoda Y; Zhou Q; Iasonos A; Tew WP; Diaz JP; Chi DS; Barakat RR; Abu-Rustum NR
Gynecol Oncol; 2008 Nov; 111(2):265-70. PubMed ID: 18774596
[TBL] [Abstract][Full Text] [Related]
6. Comparison of survival outcomes between radio-chemotherapy and radical hysterectomy with postoperative standard therapy in patients with stage IB1 to IIA2 cervical cancer: long-term oncological outcome analysis in 37 Chinese hospitals.
Liu P; Lin L; Kong Y; Huo Z; Zhu L; Bin X; Lang J; Chen C
BMC Cancer; 2020 Mar; 20(1):189. PubMed ID: 32138718
[TBL] [Abstract][Full Text] [Related]
7. Treatment outcomes in patients with FIGO stage IB-IIA cervical cancer and a focally disrupted cervical stromal ring on magnetic resonance imaging: A propensity score matching study.
Kong TW; Lee JD; Son JH; Paek J; Chun M; Chang SJ; Ryu HS
Gynecol Oncol; 2016 Oct; 143(1):77-82. PubMed ID: 27423377
[TBL] [Abstract][Full Text] [Related]
8. Pathological Risk Factors and Outcomes in Women With Stage IB2 Cervical Cancer Treated With Primary Radical Surgery Versus Chemoradiotherapy.
Bradbury M; Founta C; Taylor W; Kucukmetin A; Naik R; Ang C
Int J Gynecol Cancer; 2015 Oct; 25(8):1476-83. PubMed ID: 26244756
[TBL] [Abstract][Full Text] [Related]
9. Propensity Score Analysis of Radical Hysterectomy Versus Definitive Chemoradiation for FIGO Stage IIB Cervical Cancer.
Tomita N; Mizuno M; Makita C; Kondo S; Mori M; Sakata J; Tsubouchi H; Hirata K; Tachibana H; Kodaira T
Int J Gynecol Cancer; 2018 Oct; 28(8):1576-1583. PubMed ID: 30095702
[TBL] [Abstract][Full Text] [Related]
10. Preoperative chemoradiation followed by hysterectomy for cervical cancer: patterns of care and survival in a large, hospital database.
Albert A; Allbright R; Lee A; Vijayakumar S
J Gynecol Oncol; 2019 May; 30(3):e41. PubMed ID: 30887759
[TBL] [Abstract][Full Text] [Related]
11. A retrospective comparison of outcome in IB2 and IIA cervical cancer patients treated with primary concurrent chemoradiation versus radical hysterectomy with or without tailored adjuvant therapy.
Jang TK; Shin SJ; Chung H; Kwon SH; Cha SD; Lee E; Shin C; Cho CH
Obstet Gynecol Sci; 2017 Nov; 60(6):549-557. PubMed ID: 29184863
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopic Radical Hysterectomy in Early Stage Cervical Cancer: A Systematic Review and Meta-Analysis.
Zhao Y; Hang B; Xiong GW; Zhang XW
J Laparoendosc Adv Surg Tech A; 2017 Nov; 27(11):1132-1144. PubMed ID: 28300465
[TBL] [Abstract][Full Text] [Related]
13. Chemoradiation with and without adjuvant extrafascial hysterectomy for IB2 cervical carcinoma.
Darus CJ; Callahan MB; Nguyen QN; Pastore LM; Schneider BF; Rice LW; Jazaeri AA
Int J Gynecol Cancer; 2008; 18(4):730-5. PubMed ID: 17949426
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness comparisons of various therapies for FIGO stage IB2/IIA2 cervical cancer: a Bayesian network meta-analysis.
Cheng J; Liu B; Wang B; Long X; Li Z; Chen R; Wu R; Xu L
BMC Cancer; 2021 Oct; 21(1):1078. PubMed ID: 34615494
[TBL] [Abstract][Full Text] [Related]
15. A prospective randomized controlled study on multiple neoadjuvant treatments for patients with stage IB2 to IIA cervical cancer.
Wen H; Wu X; Li Z; Wang H; Zang R; Sun M; Huang X; Zhang Z; Cai S
Int J Gynecol Cancer; 2012 Feb; 22(2):296-302. PubMed ID: 22274319
[TBL] [Abstract][Full Text] [Related]
16. Survival and toxicity in neoadjuvant chemotherapy plus surgery versus definitive chemoradiotherapy for cervical cancer: A systematic review and meta-analysis.
Marchetti C; Fagotti A; Tombolini V; Scambia G; De Felice F
Cancer Treat Rev; 2020 Feb; 83():101945. PubMed ID: 31838220
[TBL] [Abstract][Full Text] [Related]
17. Comparison of treatment outcomes of surgery and radiotherapy, including concurrent chemoradiotherapy for stage Ib2-IIb cervical adenocarcinoma patients: a retrospective study.
Kondo E; Yoshida K; Tabata T; Kobayashi Y; Yamagami W; Ebina Y; Kaneuchi M; Nagase S; Machida H; Mikami M
J Gynecol Oncol; 2022 Mar; 33(2):e14. PubMed ID: 34910395
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant radiotherapy and chemoradiation after surgery for cervical cancer.
Rogers L; Siu SS; Luesley D; Bryant A; Dickinson HO
Cochrane Database Syst Rev; 2009 Oct; (4):CD007583. PubMed ID: 19821430
[TBL] [Abstract][Full Text] [Related]
19. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.
Yin M; Zhao F; Lou G; Zhang H; Sun M; Li C; Hou Y; Li X; Meng F; Chen X
Int J Gynecol Cancer; 2011 Jan; 21(1):92-9. PubMed ID: 21330834
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemoradiotherapy versus radiotherapy in cervical cancer patients with intermediate-risk factors: A systematic review and meta-analysis.
Li M; Hu M; Wang Y; Yang X
Eur J Obstet Gynecol Reprod Biol; 2019 Jul; 238():1-6. PubMed ID: 31082737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
